Dosage & Reconstitution Guide
KPV Dosage & Reconstitution Guide
A clear educational guide covering KPV reconstitution, unit conversions, protocol examples, supplies, storage, injection technique, inflammation research notes and safety considerations.
Quickstart Highlights
- Peptide: KPV, short for Lysine-Proline-Valine
- Common vial size: 10mg
- Example reconstitution: 3.0mL bacteriostatic water
- Resulting concentration: approximately 3.33mg/mL
- U-100 syringe maths: 1 unit = 0.01mL = approximately 33.33mcg
- Common research range discussed: 200mcg to 500mcg daily
- Common schedule discussed: once daily for 8-12 weeks
- Storage after mixing: refrigerate at 2-8°C and use within around 30 days
What is KPV?
KPV is a short tripeptide made from lysine, proline and valine. It is the C-terminal fragment of alpha-melanocyte-stimulating hormone, also known as alpha-MSH.
In research discussions, KPV is most commonly associated with anti-inflammatory pathways, immune modulation, inflammatory bowel disease models, colitis research, wound healing and systemic inflammation studies. Unlike full alpha-MSH, KPV is discussed as not having melanotropic effects, meaning it is not associated with skin pigmentation activity in the same way.
KPV Reconstitution Example
The example below is based on a common 10mg KPV vial mixed with 3.0mL bacteriostatic water.
Reconstitution Maths
10mg ÷ 3.0mL = 3.33mg/mL
3.33mg/mL = 3,333mcg/mL
1 unit on a U-100 syringe = 0.01mL
3,333mcg/mL × 0.01mL = approximately 33.33mcg per unit
KPV Unit Conversion Table
Standard Gradual Research Example
Frequency and Timing Notes
KPV is commonly discussed as a once-daily subcutaneous compound in the source protocol. Timing is not highly specific, so the main practical note is consistency, careful tracking and rotating injection sites.
Because early doses may be measured in small unit amounts, 30-unit or 50-unit insulin syringes may be easier to read than a full 1mL syringe.
Reconstitution Steps
- Confirm the vial size before calculating concentration.
- Draw 3.0mL bacteriostatic water using sterile technique.
- Inject the bacteriostatic water slowly down the inside wall of the vial.
- Avoid blasting the powder directly and avoid creating foam.
- Gently swirl or roll the vial until the powder fully dissolves.
- Do not shake aggressively.
- Label the vial with the reconstitution date and concentration.
- Store the reconstituted vial in the refrigerator at 2-8°C, protected from light.
Supplies Needed
KPV Vials
- 8-week example: approximately 3 × 10mg vials.
- 12-week example: approximately 4 × 10mg vials.
- 16-week example: approximately 6 × 10mg vials.
Insulin Syringes
- Daily example: 7 syringes per week.
- 8 weeks: approximately 56 syringes.
- 12 weeks: approximately 84 syringes.
- 16 weeks: approximately 112 syringes.
Bacteriostatic Water
- Per 10mg vial: 3.0mL bacteriostatic water.
- 8-week example: 3 vials × 3.0mL = 9mL total, so 1 × 10mL bottle is usually enough.
- 12-week example: 4 vials × 3.0mL = 12mL total, so 2 × 10mL bottles may be needed.
- 16-week example: 6 vials × 3.0mL = 18mL total, so 2 × 10mL bottles may be needed.
Alcohol Swabs
- Per administration: one swab for the vial stopper and one for the injection site.
- Per week: approximately 14 swabs based on daily administration.
- 8 weeks: around 112 swabs, so 2 × 100-count boxes may be needed.
- 12 weeks: around 168 swabs, so 2 × 100-count boxes may be needed.
- 16 weeks: around 224 swabs, so 3 × 100-count boxes may be needed.
Protocol Overview
- Goal discussed in research: systemic inflammation reduction and immune-response modulation.
- Schedule example: once-daily subcutaneous administration.
- Common amount discussed: 200-500mcg daily with gradual weekly titration.
- Example reconstitution: 3.0mL bacteriostatic water per 10mg vial.
- Concentration: approximately 3.33mg/mL.
- Cycle length: 8-12 weeks is commonly discussed, with optional extension to 16 weeks.
- Timing: any consistent time is commonly discussed.
- Storage: lyophilised frozen, reconstituted refrigerated and protected from freeze-thaw cycles.
Example Dosing Protocol
- Start: 200mcg daily.
- Titration: increase by around 100mcg weekly as tolerated.
- Target example: 400-500mcg daily by weeks 4-8.
- Frequency: once daily in the source protocol.
- Practical note: at this dilution, 500mcg is around 15 units on a U-100 syringe.
How KPV Works
KPV is the C-terminal tripeptide sequence of alpha-MSH. It is discussed as retaining anti-inflammatory activity without the melanotropic effects associated with the full hormone.
In preclinical research, KPV is discussed for reducing pro-inflammatory cytokines such as TNF-alpha, IL-6 and IL-1 beta. It is also discussed in relation to NF-kB signalling and inflammatory mediator release.
The source material highlights inflammatory bowel disease, colitis and systemic inflammation models as common research contexts for KPV.
Potential Benefits Discussed in Research
- Anti-inflammatory pathway research
- Immune-response modulation
- Inflammatory bowel disease model discussions
- Colitis research
- Systemic inflammation research
- Wound healing and tissue repair discussions
- No melanotropic effects in research discussions
- Oral and subcutaneous route research
Reported Side Effects and Limitations
- Mild injection-site redness
- Slight swelling or local irritation
- Possible discomfort if injected too quickly
- Unknown long-term outcomes outside studied settings
- Not approved for human therapeutic use
- Not a guaranteed treatment for gut inflammation, autoimmune conditions or injury
Storage Instructions
- Lyophilised powder: store frozen at around -20°C or below in dry, dark conditions.
- After reconstitution: refrigerate at 2-8°C.
- Use window: commonly discussed as within approximately 30 days after reconstitution.
- Avoid: heat, sunlight, moisture, contamination and repeated freeze-thaw cycles.
- Do not refreeze: reconstituted peptide solution should generally not be refrozen.
- Practical note: allow cold vials to reach room temperature before opening to reduce condensation exposure.
Injection Technique Notes
This section is general educational information only. It is not personal injection instruction.
- Use a new sterile insulin syringe for each administration.
- Clean the vial stopper and injection site with alcohol and allow both to dry completely.
- Common subcutaneous sites discussed include abdomen, anterior or lateral thigh and outer upper arm.
- Rotate injection sites systematically to reduce irritation and maintain consistent absorption.
- Pinch a 1-2 inch skinfold and insert into subcutaneous tissue at an appropriate angle.
- Do not aspirate for subcutaneous injections.
- Inject slowly and steadily over several seconds.
- Withdraw the needle smoothly and apply gentle pressure.
- Do not rub the site.
- Dispose of used sharps safely in a sharps container.
Lifestyle Factors That May Matter
- Anti-inflammatory diet: whole foods, omega-3 fatty acids, polyphenols and reduced processed foods are commonly discussed.
- Stress management: chronic stress may elevate inflammatory markers.
- Physical activity: regular moderate exercise may support inflammatory balance, while overtraining may do the opposite.
- Sleep: 7-9 hours of quality sleep is commonly discussed for immune regulation and inflammatory homeostasis.
- Gut health: fibre intake and probiotic-rich foods are commonly discussed in inflammatory bowel contexts.
- Tracking: documenting amount, date, site and observations can make tolerance patterns easier to review.
Use the Peptide Calculator
If your vial size, water volume or target amount is different, use the Peptide Hub Australia calculator to work out concentration, mL and syringe units.
Calculate KPV Units
Enter your vial size, BAC water amount and target amount to calculate concentration and syringe units.
Open Peptide CalculatorWhere to Compare KPV Suppliers
Peptide Hub Australia does not sell KPV or any other peptides. We compare Australian peptide vendors, package audits, pricing and supplier information to help users review the market more clearly.
Frequently Asked Questions
How much BAC water do you add to a 10mg KPV vial?
A common educational example is 3.0mL bacteriostatic water added to a 10mg vial, creating a concentration of approximately 3.33mg/mL.
How many units is 200mcg of KPV?
If a 10mg vial is mixed with 3.0mL, 200mcg is approximately 6 units on a U-100 insulin syringe, equal to around 0.06mL.
How many units is 500mcg of KPV?
If a 10mg vial is mixed with 3.0mL, 500mcg is approximately 15 units on a U-100 insulin syringe, equal to around 0.15mL.
How long does one 10mg KPV vial last?
At 500mcg daily, one 10mg vial contains around 20 administrations. At 200mcg daily, it contains around 50 administrations, although the reconstituted storage window still matters.
Is KPV the same as alpha-MSH?
No. KPV is a short tripeptide fragment of alpha-MSH. It is discussed as retaining anti-inflammatory activity without the melanotropic effects of the full hormone.
Is KPV used for gut inflammation?
KPV is discussed in inflammatory bowel disease and colitis research models, but it should not be presented as a proven treatment for gut inflammation or any medical condition.
Does KPV affect skin pigmentation?
The source protocol notes that KPV does not have the melanotropic effects associated with full alpha-MSH.
Is this a personal dosing recommendation?
No. This page is an educational reconstitution and measurement guide only. It is not medical advice or a personal protocol.
